Sun-Novo: The first-instance judgment of the lawsuit requires Hang Seng Pharmaceutical to pay 2.4032 million yuanZhitong·Nov 3, 2025 at 08:40 AM688621-1.49%
Sun-Novo: Plans to acquire Langyan Life and increase its shareholding to over 30%Zhitong·Oct 31, 2025 at 10:46 AM688621-1.49%
Sun-Novo plans to invest 15 million yuan in JiaoYuanMa ZhiYaoZhitong·Oct 19, 2025 at 07:37 AM688621-1.49%
Sun-Novo: BTP4507 has received the notification of approval for clinical trialsZhitong·Oct 12, 2025 at 08:34 AM688621-1.49%
Pacific Securities: The pharmaceutical industry is stabilizing and improving, with signs of recovery already visibleZhitong·Sep 16, 2025 at 01:26 AM688621-1.49%
CRO concept fluctuates and strengthens, Boteng Co., Ltd. rises over 9%Zhitong·Sep 15, 2025 at 02:47 AM688621-1.49%603127-2.82%
The A-share CRO concept sector has seen a surge, with Lionco hitting the daily limit, MeHow rising over 10%, and Haoyuan Pharmaceutical, Boji Pharmaceutical, Medicilon, Sun-Novo, and Heyuan Biotechnology also following suitZhitong·Aug 25, 2025 at 02:14 AM688202-5.42%688621-1.49%
The concept of innovative drugs is active again, Shen Lian Biomedical has achieved a two-day limit upZhitong·Aug 18, 2025 at 01:37 AM688336-3.42%688098-0.37%
Innovative drug concept stocks show unusual upward movement, Sun-Novo rises over 10%Zhitong·Aug 7, 2025 at 01:39 AM688621-1.49%002923-2.30%
The medical services sector surged sharply, with Sun-Novo rising over 10%Zhitong·Aug 7, 2025 at 01:35 AM688621-1.49%
Innovative drug concept stocks saw a partial rebound, with Hanyu Pharmaceutical surging over 10% in the afternoon, Hicin Pharmaceutical, Sun-Novo, and Guangshengtang also rising over 10%. Fuyuan Pharmaceutical and WEDGE CORPORATION hit the daily limit, while Longshen Rongfa, JINGXIN, CSBIO, and Staidson BioPharm followed suitZhitong·Aug 4, 2025 at 05:09 AM300584-2.72%688621-1.49%
Bank of China International: The Medical Insurance Bureau clarifies that centralized procurement is against involution, focusing on re-evaluation opportunities in the pharmaceutical sectorZhitong·Jul 30, 2025 at 08:19 AM603233-1.39%688621-1.49%
The cell immunotherapy sector is partially active, with Sanyuan Gene rising over 12%Zhitong·Jul 29, 2025 at 02:06 AM688621-1.49%603127-2.82%
CRO concept stocks perform actively, Medicilon rises nearly 18%Zhitong·Jul 17, 2025 at 06:29 AM688202-5.42%688222-2.49%
The CRO index's intraday increase expanded to 3%, Medicilon hit the limit up, JOINN, Bide, Sun-Novo, and INNOSTAR followed suitZhitong·Jul 9, 2025 at 03:04 AM603127-2.82%06127-2.93%
